Difference in Impact of CYP2C19 Polymorphism on Platelet Reactivity and Clinical Outcomes Between Acute Coronary Syndrome (ACS) and Stable Angina

被引:0
|
作者
Hokimoto, Seiji [1 ]
Akasaka, Tomonori [1 ]
Kaikita, Koichi [1 ]
Nakagawa, Kazuko [2 ]
Ogawa, Hisao [1 ]
机构
[1] Kumamoto Univ, Dept Cardiovasc Med, Kumamoto, Japan
[2] Kumamoto Univ, Div Pharmacol & Therapeut, Kumamoto, Japan
关键词
Acute coronary syndromes; Pharmacogenetics; Percutaneous coronary intervention; Genetics;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
16546
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
    Mega, Jessica L.
    Hochholzer, Willibald
    Frelinger, Andrew L., III
    Kluk, Michael J.
    Angiolillo, Dominick J.
    Kereiakes, Dean J.
    Isserman, Steven
    Rogers, William J.
    Ruff, Christian T.
    Contant, Charles
    Pencina, Michael J.
    Scirica, Benjamin M.
    Longtine, Janina A.
    Michelson, Alan D.
    Sabatine, Marc S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (20): : 2221 - 2228
  • [22] Prognostic Impact of CYP2C19 Genotypes on Long-Term Clinical Outcomes in Older Patients After Percutaneous Coronary Intervention
    Kim, Ju Hyeon
    Lee, Seung-Jun
    Cha, Jung-Joon
    Park, Jae Hyoung
    Hong, Soon Jun
    Ahn, Tae Hoon
    Kim, Byeong-Keuk
    Chang, Kiyuk
    Park, Yongwhi
    Song, Young Bin
    Ahn, Sung Gyun
    Suh, Jung-Won
    Lee, Sang Yeub
    Cho, Jung Rae
    Her, Ae-Young
    Jeong, Young-Hoon
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Shin, Eun-Seok
    Lim, Do-Sun
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (10):
  • [23] The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease
    El-Khodary, N. M.
    El-Behery, A. M.
    El-Askary, N. A.
    Donia, H. M.
    Omran, G. A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (19) : 6065 - 6076
  • [24] The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study
    Bhatt, Deepak L.
    Pare, Guillaume
    Eikelboom, John W.
    Simonsen, Katy L.
    Emison, Eileen S.
    Fox, Keith A. A.
    Steg, Ph Gabriel
    Montalescot, Gilles
    Bhakta, Nihar
    Hacke, Werner
    Flather, Marcus D.
    Mak, Koon-Hou
    Cacoub, Patrice
    Creager, Mark A.
    Berger, Peter B.
    Steinhubl, Steven R.
    Murugesan, Gurunathan
    Mehta, Shamir R.
    Kottke-Marchant, Kandice
    Lincoff, A. Michael
    Topol, Eric J.
    EUROPEAN HEART JOURNAL, 2012, 33 (17) : 2143 - 2150
  • [25] CYP2C19*2 and prognosis after an acute coronary syndrome: Insights from a Portuguese center
    Teixeira, Rogerio
    Monteiro, Pedro
    Marques, Gilberto
    Pego, Joao
    Lourenco, Margarida
    Tavares, Carlos
    Reboredo, Alda
    Monteiro, Silvia
    Goncalves, Francisco
    Ferreira, Maria J.
    Freitas, Mario
    Ribeiro, Graca
    Providencia, Luis A.
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (04) : 265 - 273
  • [26] Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays
    Tsantes, Argirios E.
    Ikonomidis, Ignatios
    Papadakis, Ioannis
    Bonovas, Stefanos
    Gialeraki, Argiri
    Kottaridi, Christine
    Kyriakou, Elias
    Kokori, Styliani
    Douramani, Panagiota
    Kopterides, Petros
    Karakitsos, Petros
    Lekakis, John
    Kapsimali, Violetta
    THROMBOSIS RESEARCH, 2013, 132 (02) : E105 - E111
  • [27] Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
    Klein, Melissa D.
    Williams, Alexis K.
    Lee, Craig R.
    Stouffer, George A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (04) : 647 - 652
  • [28] Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS
    Peng, Li
    Liu, Jun
    Qin, Liuan
    Liu, Jia
    Xi, Shaozhi
    Lu, Caiyi
    Yin, Tong
    THROMBOSIS RESEARCH, 2017, 157 : 97 - 102
  • [29] Vascular Endothelial Function and Platelet Reactivity by Gender Differences Based on CYP2C19 Polymorphism are Associated With Cardiovascular Events Risk in Patients Undergoing Percutaneous Coronary Intervention (PCI)
    Hokimoto, Seiji
    Akasaka, Tomonori
    Kaikita, Koichi
    Nakagawa, Kazuko
    Arima, Yuichiro
    Ogawa, Hisao
    CIRCULATION, 2013, 128 (22)
  • [30] Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting
    Stimpfle, Fabian
    Karathanos, Athanasios
    Droppa, Michal
    Metzger, Janina
    Rath, Dominik
    Mueller, Karin
    Tavlaki, Elli
    Schaeffeler, Elke
    Winter, Stefan
    Schwab, Matthias
    Gawaz, Meinrad
    Geisler, Tobias
    THROMBOSIS RESEARCH, 2014, 134 (01) : 105 - 110